INTRODUCTION
============

Stability ball use has been investigated for its potential to increase muscular activity during core muscle exercises ([@b2-ijes_05_04_360],[@b10-ijes_05_04_360],[@b12-ijes_05_04_360]) and as a replacement for chair sitting ([@b7-ijes_05_04_360],[@b11-ijes_05_04_360]) in an effort to aid in preventing or attenuating low back pain. However, until recently there have been no reports on the impact of using the stability ball during aerobic exercise. This is understandable since using the stability ball during most aerobic activities seems unpractical. But arm ergometry generally involves sitting on a chair which can be easily replaced by a stability ball. Arm ergometry has been used for upper body aerobic training ([@b3-ijes_05_04_360],[@b4-ijes_05_04_360],[@b5-ijes_05_04_360]) in fitness centers, cardiac rehabilitation, and spinal cord injury rehabilitation.

One of the limiting features of arm ergometry is that despite the higher VO~2~ at a given power output when compared to leg exercise ([@b5-ijes_05_04_360],[@b8-ijes_05_04_360]) the potential total energy expenditure is expected to be lower than leg exercise because of the arm's lower peak VO~2~ ([@b5-ijes_05_04_360],[@b8-ijes_05_04_360]). This limits arm exercise as a means to expend energy for body fat loss programs. The addition of a stability ball could elevate VO~2~ and thus energy expenditure. This laboratory has reported that stability ball sitting elevates sub-maximal VO~2~ 10% to 16% ([@b9-ijes_05_04_360]). Another concern is the impact the stability ball could have on heart rate during arm exercise. It has been shown that arm ergometry has higher heart rates at a given power output than leg exercise ([@b5-ijes_05_04_360],[@b8-ijes_05_04_360]) and the addition of a stability ball might be expected to increase heart rates further. However, our laboratory has demonstrated that the stability ball may not impact heart rates during sub-maximal arm ergometry ([@b9-ijes_05_04_360]). Maximal or peak levels are important for exercise prescription and to evaluate exercise training programs. The only known study to report on the impact of stability ball sitting during arm ergometry was limited to sub-maximal exercise ([@b9-ijes_05_04_360]).

The purpose of this study was to determine if sitting on a stability ball results in greater cardiorespiratory responses to continuous graded arm exercise to exhaustion and look at the potential impact on exercise prescription concerns.

METHODS
=======

Participants
------------

Twenty-seven apparently healthy female and male adult participants were recruited after the University Institutional Review Board approval. Criteria for participation included absence of cardiac, pulmonary, and metabolic disease, 18 to 40 years of age, and be at least moderately active (3 days/week of walking 30 minutes e.g.).

Protocol
--------

When a participant first entered the laboratory the informed consent was obtained and the participant had to answer no to all questions on the Physical Activity Readiness Questionnaire ([@b1-ijes_05_04_360]) in order to continue on that day for exercise testing. The participant then practiced sitting on the ball, cranking at 50 revolutions per minute (rpm), and was familiarized with the blood pressure procedure. Sitting heights---right shoulder height to floor---on the chair and ball were measured using a stadiometer to ensure sitting heights were about equal; a wooden platform was placed under the lower sitting mode to adjust the sitting height to be within two centimeters of the other. Body mass was also measured using a balance scale (Detecto, Webb, MO).

Following the initial procedures, the participant then underwent two graded exercise tests to exhaustion: one on the chair (44 cm seat height unless adjusted) and one on a stability ball (75 cm diameter) with a one hour rest between. This time frame was chosen to replicate our earlier study's design for possible comparisons ([@b9-ijes_05_04_360]). The participants were instructed to position the chair (without back support) or ball and their feet in ways that were most comfortable to them. The two tests started with four minutes of rest then began continuous graded exercise at 15 W or 30 W (smaller individuals with little upper body exercise experience started at the 15 W) that increased 15 W every four minutes until the participant was unable to maintain the 50 rpm. Individuals were continuously encouraged to maintain the 50 rpm throughout the test. When an individual could no longer get back to 50 rpm or sustain it for 10 seconds or more after encouragement, the test was terminated. We made sure that all participants had 30 W and 45 W stages so that we could make some comparisons to our earlier study. Once the graded exercise test was terminated, the participants went into a two minute active recovery period (zero load at a self-paced rpm). Following this, 60 minutes of rest occurred between the two exercise tests. The participants read, did paper work, worked on their computers, etc. during the rest period. No food was taken and only water was ingested between tests. The order of sitting mode was randomized by the following: each participant was assigned an ID number. For odd numbered ones a coin was tossed to determine whether to start with the chair or stability ball, the subsequent even numbered participant was assigned to the other sitting mode.

An arm ergometer (Monark 818, Sweden) was used for the exercise test with the revolution rate goal set at 50 rpm. During the tests oxygen consumption (VO~2~) was continuously measured by open-circuit spirometry (MAX-I, AEI Technologies, Naperville, IL). The MAX-I was calibrated using 4.00% CO~2~ and 16.00% O~2~ before each exercise session. Heart Rate (HR) was continuously recorded using a Polar monitor (Polar Electro Inc., Woodbury, NY) with the sensor connected to the MAX-I computer. Systolic (SBP) and Diastolic (DBP) blood pressures were measured on the left arm after three minutes of rest and after the third minute of each stage of exercise in order not to affect each stage's VO~2~ and HR measurements. An aneroid sphygmomanometer and stethoscope were used to measure SBP and DBP with the following procedure: power output was reduced by half the wattage for that stage while the participant maintained the 50 rpm with the right arm and while the blood pressure was measured on the left arm.

Measurements at the 30 W, 45 W, Penultimate, and Peak stages were analyzed. The average VO~2~ and HR from two and a half minutes to the third minute of rest and two and a half minutes to the third minute each stage of exercise were used for evaluations. VO~2~ and HR were also expressed as a percentage of their peak levels. Peak VO~2~ in mL·kg^−1^· min^−1^ was also calculated.

Statistical Analysis
--------------------

A 2 (sitting mode) × 4 (Power Output) repeated measures ANOVA was used with significance set at α ≤ 0.05. If a significant main effect for sitting mode was found then paired *t* tests with Holm's Sequential Bonferroni procedure ([@b6-ijes_05_04_360]) was used for follow-up analyses. A paired *t* test was used to determine if there was a significant (α ≤ 0.05) difference between sitting modes for sitting height. SPSS version 11.5 was used for all statistical analyses. Our prior study indicated that η^2^ would be greater than 0.2 for VO~2~. Setting η^2^ = 0.2, Power = 0.80, and α ≤ 0.05, an n = 20 would be needed for a repeated measures ANOVA ([@b13-ijes_05_04_360]).

RESULTS
=======

[Table 1](#t1-ijes_05_04_360){ref-type="table"} contains the participant characteristics. Each and every participant achieved the same peak power output for both sitting modes (Mean ± SD = 103 ± 29 W, also see [Table 1](#t1-ijes_05_04_360){ref-type="table"}). The average *absolute* difference between the stability ball and chair for time to exhaustion was 0.2 minutes; however, the average time to exhaustion was 18.0 ± 2.6 minutes on the ball and 17.9 ± 2.6 minutes on the chair and did not differ significantly (*P* = 0.458).

[Table 2](#t2-ijes_05_04_360){ref-type="table"} contains the mean ± SD for VO~2~ and HR for the two sitting modes during 30 W, 45 W, Penultimate, and Peak stages. ANOVA for repeated measures revealed significant main effects (sitting mode and power output, *P* \< 0.001) and interaction (*P* = 0.013) for VO~2~. Paired *t* tests with Holm's Sequential Bonferroni procedure demonstrated that VO~2~ was significantly (*P* \< 0.001) higher by 8% to 12% on the stability ball for all four stages of exercise. Average peak VO~2~ was 30.5 ± 4.1 mL·kg^−1^· min^−1^ on the stability ball and 27.6 ± 4.5 mL·kg^−1^· min^−1^ on the chair. In addition, HR had significant power output and sitting mode main effects (*P* \< 0.001 and *P* = 0.003, respectively) and non-significant interaction (P = 0.361). Paired *t* tests with Holm's Sequential Bonferroni procedure demonstrated that HR was significantly (*P* \< 0.001) higher by 3% and 2% on the stability ball for the Penultimate and Peak stages, respectively but not significantly different for the 30 W (*P* = 0.161) and 45 W (*P* = 0.097). [Table 3](#t3-ijes_05_04_360){ref-type="table"} expresses the VO~2~ and HR results as a percentage of peak levels. As a percentage of peak, VO~2~ had non-significant sitting mode main effect (*P* = 0.394) and interaction (*P* = 0.138). In addition, HR as a percentage of peak levels had no significant sitting mode main effect (*P* = 0.589) and interaction (*P* = 0.538).

[Table 4](#t4-ijes_05_04_360){ref-type="table"} contains the mean ± SD for SBP and DBP for the two sitting modes during 30 W, 45 W, Penultimate, and Peak stages. Regarding SBP, there was a significant (*P* \< 0.001) power output main effect. Sitting mode main effect and interaction were not significant (*P* = 0.072 and *P* = 0.076, respectively). Regarding DBP, there was a significant (*P* \< 0.011) power output main effect. Sitting mode main effect and interaction were not significant (*P* = 0.294 and *P* = 0.618, respectively).

Though HR and SBP were little or non-significantly affected by the stability ball, their double product had significant sitting mode (*P* =.009) and power output (*P* \<.001) main effects and no significant interaction (*P*=.881). The stability balls double products were 4 to 8% higher than the chair's.

DISCUSSION
==========

This is the first study to investigate cardiorespiratory responses during peak arm ergometry while sitting on a stability ball. Compared to chair sitting, sitting on the stability ball resulted in significantly higher VO~2~ across all four stages and significantly higher HR at the Penultimate and Peak stages. There are a few differences between our earlier study ([@b9-ijes_05_04_360]) and this study: this study controlled for seat height, its practice session was done on the same day as testing, and its participants exercised to fatigue. Even with these differences, the impact of sitting on the stability ball on VO~2~ (increase compared to chair) was similar: 13% and 10% in prior study and 9% and 12% in this study at 30 W and 45 W, respectively. It appears that this study confirms our earlier findings on sub-maximum VO~2~ and demonstrates that the effect continues to peak VO~2~. Though peak VO~2~ was higher on the stability ball, peak time to exhaustion remained the same. This and the higher VO~2~ with all stages may indicate greater muscle recruitment with the stability ball in non-arm muscles. Our earlier work had significantly higher EMG activity in the rectus femoris and external oblique muscles with the stability ball ([@b9-ijes_05_04_360]). Leg and trunk muscles were probably recruited to stabilize the trunk and lower body.

The HR results in this study also were similar to our prior study: non-significant differences between the stability ball and chair at the 30 W and 45 W stages. However, we did find significantly higher HRs at the Penultimate and Peak stages for stability ball sitting but they were relatively small (3% and 2%, respectively) compared to the VO~2~ increases (8% and 10%, respectively). These results confirm our earlier study's finding but indicate that it does not extend to near peak and peak HR but again the effect is small. The small effect is not surprising given the impact of an already increased heart rate brought about by upper body exercise ([@b5-ijes_05_04_360],[@b8-ijes_05_04_360]) and the relatively small potential increase in HR compared to VO~2~ increases (75 to 180 b/min compare to 250 mL/min to 2000 mL/min e.g.). As discussed in our prior study ([@b9-ijes_05_04_360]), the HR results indicate that stroke volume, oxygen content difference or both deliver(s) the extra oxygen with stability ball sitting. Even though the Penultimate and Peak stages' HRs were higher in this study, they were higher by a relatively smaller amount compared to the increased VO~2~ at those stages and again indicate other cardiac/hematological parameters contributing to the extra oxygen delivery.

There were no significant differences between sitting modes for blood pressure and confirms our earlier findings. If other studies continue to demonstrate no significant effects of the stability ball (compared to chair) on SBP, then this may indicate that one can elevate the metabolic response to arm ergometry without perhaps elevating the cardiac oxygen demands. However, we did find the double product to be 4--8% higher on the stability ball compared to the chair.

Our earlier study ([@b9-ijes_05_04_360]) discussed implications of using the stability ball during arm ergometry for weight loss programs (higher stability ball VO~2~ leads to higher energy expenditure) and cardiac rehabilitation programs (higher submaximal VO~2~ without higher HR and SBP). In addition, we discussed that the higher VO~2~ indicated higher MET levels at a given power output and needed to be considered if intensity is prescribed in absolute MET levels. The current study does not change that implication for absolute MET levels, however, since the relationship between percentage of peak VO~2~ and percentage of peak HR does not appear to differ between the stability ball and chair sitting ([Table 3](#t3-ijes_05_04_360){ref-type="table"}), this indicates that an individual's exercise prescription based on percentage of peak VO~2~ or HR is not different for a given wattage between the stability ball and chair sitting modes.

This study limited the participants to apparently healthy young adults and used the same diameter ball for every participant. It would be of interest to study older participants and individuals in cardiac rehabilitation to determine if they have the same VO~2~, HR, and blood pressure responses as our participants. In addition, it would be interesting to determine if the stability ball results in any training benefits over the chair. We limited our reporting of submaximal data to 30 W and 45 W to compare to our earlier work, expanding this research to incorporate a greater number of power output levels is warranted. We did limit the rest period to only one hour to approximate the conditions of our earlier work. However, this could attenuate any differences if recovery was not sufficient. We have not explored the impact of stability ball size or pressure or compare other types of sitting furniture with arm ergometry. Within these limitations, this study's results indicate that for apparently healthy young male and female adults, sitting on the stability ball during arm ergometry significantly elevates oxygen consumption without significantly affecting sub-maximal cardiovascular parameters but has a relatively smaller increase in HRs at high intensity. In addition, it appears that exercise prescription based on % peak VO~2~ or % peak HR from arm ergometry chair sitting can still be used when replacing the chair with a stability ball.
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###### 

Participant characteristics (Mean ± SD).

            n    Age (yrs)   Body Mass (kg)   Peak Power Output (W)
  --------- ---- ----------- ---------------- -----------------------
  Females   13   21 ± 2      60.6 ± 7.2       84 ± 18
  Males     14   22 ± 1      75.0 ± 5.5       121 ± 25

###### 

Impact of sitting mode on VO~2~ and HR during arm ergometry (Mean±SD).

           VO~2~ (mL· min^−1^)                                       HR (b·min^−1^)                                                           
  -------- --------------------------------------------------------- ---------------- ------------------------------------------------------- --------
  30 W     743±115[\*](#tfn1-ijes_05_04_360){ref-type="table-fn"}    680±108          106±13                                                  104±16
  45 W     971±121[\*](#tfn1-ijes_05_04_360){ref-type="table-fn"}    869±100          121±17                                                  118±19
  Penult   1609±319[\*](#tfn1-ijes_05_04_360){ref-type="table-fn"}   869±100          161±14[\*](#tfn1-ijes_05_04_360){ref-type="table-fn"}   156±15
  Peak     2087±475[\*](#tfn1-ijes_05_04_360){ref-type="table-fn"}   1893±449         178±10[\*](#tfn1-ijes_05_04_360){ref-type="table-fn"}   174±10

Paired *t* test *P* \< 0.001 between Ball and Chair

###### 

VO~2~ and HR as a percentage of peak values (Mean±SD).

           VO~2~ (%)   HR (%)          
  -------- ----------- -------- ------ ------
  30 W     40±8        37±8     60±6   60±7
  45 W     49±10       48±11    68±8   67±9
  Penult   78±7        80±7     90±4   89±5

###### 

Sitting mode impact on blood pressure during arm ergometry (Mean±SD).

           SBP (mm Hg)   DBP (mm Hg)           
  -------- ------------- ------------- ------- -------
  30 W     121±11        114±26        76±10   79±10
  45 W     131±12        127±11        80±10   80±10
  Penult   146±12        146±14        82±13   83±12
  Peak     149±11        150±13        84±13   86±12
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